Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04755777 · ClinicalTrials.gov registry record
Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 138
- Enrollment target
NCT04755777: Completed study, sponsored by Mayo Clinic.
NCT04755777 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 138 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04755777 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 138 participants
- Enrollment target
Study Summary
The purpose of the study is to characterize various healthcare practitioners' perspectives on implementation of beta-lactam therapeutic drug monitoring in critical care practice.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2020-10-22 |
| Est. Completion | 2022-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04755777
The ClinicalTrials.gov registry entry for NCT04755777 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04755777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04755777 about?
NCT04755777 is a clinical study titled "Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill". The purpose of the study is to characterize various healthcare practitioners' perspectives on implementation of beta-lactam therapeutic drug monitoring in critical care practice.
What is the current status of trial NCT04755777?
This trial is currently completed. The enrollment target is 138 participants. The study started on 2020-10-22. Estimated completion is 2022-12-31.
Who is sponsoring clinical trial NCT04755777?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.